Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Pastimes : Clown-Free Zone... sorry, no clowns allowed -- Ignore unavailable to you. Want to Upgrade?

To: reaper who wrote (194415)	9/30/2002 5:44:33 PM
From: EepOpp	Respond to of 436258

sign of a bottom? That dang market can be quite depressing.<g> biz.yahoo.com Reuters Company News Forest Labs says to exceed 2nd-qtr estimates Monday September 30, 4:24 pm ET NEW YORK, Sept 30 (Reuters) - Drug company Forest Laboratories Inc. (NYSE:FRX - News) said on Monday it would significantly exceed analysts' earnings estimates for its fiscal second quarter because of strong sales of antidepressant drugs. New York-based Forest said it would exceed the estimate of 57 cents per share, as tracked by Thomson First Call, by at least 30 percent. The company said its sales in the quarter were about $530 million, including sales of $388 million for the antidepressant drug Celexa. Shares in Forest Laboratories closed up 7 cents at $82.01 on the New York Stock Exchange.